Get 20% lifetime commission for referring investors to digrin.com
here.
Inovio Pharmaceuticals, Inc. ( INO) - Key Metrics
INO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.07 | -$485.39 | -$485.39 |
| 2026Q1 | $0 | -$0.28 | -$0.31 | -$0.31 |
| 2025Q4 | $0 | $0.05 | -$0.28 | -$0.28 |
| 2025Q3 | $0 | -$0.87 | -$0.41 | -$0.41 |
| 2025Q2 | $0 | -$0.61 | -$0.54 | -$0.54 |
INO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.93 |
| 2026Q1 | 0% | -1.55 |
| 2025Q4 | 0% | 7.97 |
| 2025Q3 | 0% | -0.67 |
| 2025Q2 | 0% | -0.84 |
INO
Price: $1.20
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.03 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.8 million
Ebitda: -28.0 millionMarket Capitalization: 112.6 million